| Serial Number | 98806917 |
| Word Mark | FAYUVI |
| Filing Date | Thursday, October 17, 2024 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Monday, October 6, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 6, 2025 |
| Goods and Services | Providing medical services in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; medical consulting services in the field of genetic, central nervous system, and lysosomal storage diseases and disorders; healthcare services, namely, providing an online database of medical and healthcare information in the field of genetic, central nervous system, and lysosomal storage diseases and disorders, featuring inputting and collection of data and information on genetic, central nervous system, and lysosomal storage diseases and disorders for screening, diagnosis and treatment purposes; medical information services in the nature of providing a database in the field of genetic, central nervous system, and lysosomal storage disease and disorder information based on collected patient data and information all for treatment and diagnostic purposes; providing medical services, namely, gene therapy design and delivery services being gene therapy medical services in the field of genetic, central nervous system, and lysosomal storage diseases and disorders |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, October 17, 2024 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Ultragenyx Pharmaceutical Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Novato, CA 94949 |
| Party Name | Ultragenyx Pharmaceutical Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Novato, CA 94949 |
| Event Date | Event Description |
| Thursday, October 17, 2024 | NEW APPLICATION ENTERED |
| Thursday, October 17, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 24, 2025 | ASSIGNED TO EXAMINER |
| Monday, March 31, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 31, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, March 25, 2025 | NON-FINAL ACTION E-MAILED |
| Tuesday, March 25, 2025 | NON-FINAL ACTION WRITTEN |
| Tuesday, March 25, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 31, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, April 5, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, May 6, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 6, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Monday, October 6, 2025 | SOU EXTENSION 1 FILED |
| Monday, October 6, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, October 6, 2025 | SOU EXTENSION 1 GRANTED |
| Tuesday, October 7, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, July 1, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, April 30, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |